Failure of Medical Therapy in Pulmonary Arterial Hypertension Is There an Alternative Diagnosis?

被引:21
|
作者
Harch, Susan [1 ]
Whitford, Helen [2 ]
McLean, Catriona [1 ]
机构
[1] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic 3181, Australia
[2] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic 3181, Australia
关键词
VENOOCCLUSIVE DISEASE; PROSTACYCLIN; BOSENTAN; EDEMA;
D O I
10.1378/chest.08-2006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Despite the development of targeted therapies for pulmonary arterial hypertension (PAH), some patients fail to respond to medical therapy. There are a number of types of PAH, one of which is pulmonary venoocclusive disease (PVOD). Unlike other PAH types, the hallmark pathology of PVOD is fibrous occlusion of the small venules, potentially with arterial involvement. It was hypothesized that a lack of response to medical therapy in clinically diagnosed PAH can be explained by misdiagnosed PVOD. Methods: This study reviewed cases of 14 patients with clinically diagnosed PAH who had failed to respond to medical therapy and had lung tissue available from autopsy or explant. Control samples (n = 6) were obtained from lungs explanted for other causes, and at previous transthoracic echocardiogram excluded pulmonary hypertension. Comprehensive vessel morphometry was performed, and the clinical data reviewed. Results: Vessel analysis confirmed 86% of case patients had PVOD and 14% had arterial-only PAH (artPAH). In the PVOD case patients, significant pathology was present in all vessel types with similar obstructive, intimal fibrosis in the venules (p < 0.0001) and arterioles (p < 0.0001). This was considerably different from the intimal concentric laminar smooth muscle proliferation in the artPAH cases. There were no significant differences in clinical presentation between PVOD and artPAH case patients. Pulmonary edema was not observed in the PVOD cases. Conclusions: PVOD is an underdiagnosed and commonly, misdiagnosed cause of pulmonary hypertension, which may present with a failure to respond to medical therapy. Further studies on PVOD may help confirm whether a change in its classification as a type of PAH is necessary. (CHEST 2009; 135:1462-1469)
引用
收藏
页码:1462 / 1469
页数:8
相关论文
共 50 条
  • [1] Medical therapy for pulmonary arterial hypertension
    Driscoll, James A.
    Chakinala, Murali M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (01) : 65 - 81
  • [2] Diagnosis and therapy of pulmonary arterial hypertension
    Pizarro, Carmen
    Nickenig, Georg
    Skowasch, Dirk
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (23) : 1491 - 1497
  • [3] An Update on Medical Therapy for Pulmonary Arterial Hypertension
    Yan Wu
    Dermot S. O’Callaghan
    Marc Humbert
    Current Hypertension Reports, 2013, 15 : 614 - 622
  • [4] Advances in medical therapy for pulmonary arterial hypertension
    Sisniega, Carlos
    Zayas, Nayeli
    Pulido, Tomas
    CURRENT OPINION IN CARDIOLOGY, 2019, 34 (01) : 98 - 103
  • [5] Medical Therapy for Pediatric Pulmonary Arterial Hypertension
    Tissot, Cecile
    Ivy, David Dunbar
    Beghetti, Maurice
    JOURNAL OF PEDIATRICS, 2010, 157 (04): : 528 - 532
  • [6] An Update on Medical Therapy for Pulmonary Arterial Hypertension
    Wu, Yan
    O'Callaghan, Dermot S.
    Humbert, Marc
    CURRENT HYPERTENSION REPORTS, 2013, 15 (06) : 614 - 622
  • [7] Advanced Diagnosis and Therapy for Pulmonary Arterial Hypertension
    Qi, Jing
    Xing, Yan
    Zhao, Xiaoting
    Zhu, Daling
    Zheng, Xiaodong
    NANO LIFE, 2020, 10 (1-2)
  • [8] Update in the diagnosis and therapy for pulmonary arterial hypertension
    Zagolin B, Mnica
    Wainstein G, Eduardo
    Uriarte G, Polentzi
    REVISTA MEDICA DE CHILE, 2006, 134 (07) : 902 - 909
  • [9] Risk stratification and medical therapy of pulmonary arterial hypertension
    Galie, Nazzareno
    Channick, Richard N.
    Frantz, Robert P.
    Gruenig, Ekkehard
    Jing, Zhi Cheng
    Moiseeva, Olga
    Preston, Ioana R.
    Pulido, Tomas
    Safdar, Zeenat
    Tamura, Yuichi
    McLaughlin, Vallerie V.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (01)
  • [10] Medical Therapy for Heart Failure Associated With Pulmonary Hypertension
    Zelt, Jason G. E.
    Chaudhary, Ketul R.
    Cadete, Virgilio J.
    Mielniczuk, Lisa M.
    Stewart, Duncan J.
    CIRCULATION RESEARCH, 2019, 124 (11) : 1551 - 1567